Cystic fibrosis (CF) is a fatal genetic disease characterized by chronic lung infections due to aberrant 1 6 mucus production and the inability to clear invading pathogens. The traditional view that CF infections 1 7 are caused by a single pathogen has been replaced by the realization that the CF lung usually is colonized 1 8 by a complex community of bacteria, fungi and viruses. To help unravel the complex interplay between 1 9 the CF lung environment and the infecting microbial community, we developed a community metabolic 2 0 CF lung metabolomics and 16S sequencing could provide important insights into disease progression and 3 2 treatment efficacy. 3 3 Importance 3 4
The CF airway communities exhibited a substantial degree of sample-to-sample heterogeneity when rare 1 7 1 pathogens were present ( Figure 2A ) or absent ( Figure 2B ). We performed simulations to assess the extent 1 7 2 to which sample-to-sample differences in taxonomic group reads could be explained by heterogeneity in 1 7 3 the metabolic environment of the CF lung. More specifically, we randomized the community nutrient 1 7 4 uptake rates around their nominal values (Materials and Methods; Table S4 ) to mimic heterogeneous lung 1 7 5 environments shown to occur across CF patients (40, 41) and in longitudinal samples from a single 1 7 6 patient (42). Each simulation with a set of randomized uptake rates was termed a "simulated sample," and 1 7 7
we tested the hypothesis that the experimental samples could be interpreted as having been drawn from 1 7 8 the much larger set of simulated samples we generated. Due to the relatively small number of 1 7 9
Enterobacteriaceae/Escherichia-, Burkholderia-and Achromobacter-containing samples, we only 1 8 0 performed 100 randomized community simulations for each of these pathogens. By contrast, 1000 1 8 1 randomized simulations were performed for communities without these three rare pathogens since the 1 8 2 associated patient sample size was comparatively large. The single model simulation that best represented 1 8 3 a particular patient sample was determined by the minimum least-squares error between the normalized 1 8 4 measured reads and the predicted abundances across all simulations. For the 8 rare pathogen-containing 1 8 5 samples, we plotted the measured reads and predicted abundances of the five most common genera 1 8 6 (Pseudomonas, Streptococcus, Prevotella, Haemophilus, Staphylococcus) and the pathogen of interest. 1 8 7
For the remaining 67 samples, we plotted the five most common genera plus the next most abundant 1 8 8 genus according to measured reads. 1 8 9
Randomized nutrient simulations were able to generate model predictions that reproduced the major 1 9 0 features of the 3 Enterobacteriaceae/Escherichia-containing samples ( Figure 4A ), including the high 1 9 1 1 0 1 2 data variance (Table S6 ). The model ensemble was able to reproduce most of the observed variability as 2 4 5 reflected by the cloud of model simulations overlapping most of the patient samples ( Figure 6A ). The 2 4 6 patient and simulated samples covered the same range of the first PC, which was heavily weighted by 2 4 7
Pseudomonas, Streptococcus and Prevotella (Table S6) . Importantly, this consistency shows that 2 4 8 heterogeneity across these three dominant genera could be predicted from variations in the CF lung 2 4 9 metabolic environment, as we hypothesized. 2 5 0
The model ensemble also could reproduce variations in the second PC, which was heavily weighted by 2 5 1 the three dominant genera and Haemophilus, for sufficiently large values of the first PC, which 2 5 2 corresponded to relatively high Pseudomonas and low Streptococcus and Prevotella. By contrast, the 2 5 3 model ensemble did not cover the patient samples in the lower left quadrant of the PC plot ( Figure 6B ). 2 5 4
These samples were characterized by unusual combinations of relatively high Prevotella, Haemophilus, 2 5 5
Rothia and/or Fusobacterium that the model could not reproduce in its present form. Of these 12 poorly 2 5 6 modeled samples, Prevotella was highly represented in 8 samples. When the normalized reads of these 8 2 5 7 samples and their associated best-fit abundances were averaged, the models overpredicted Pseudomonas, 2 5 8
Streptococcus and Staphylococcus at the expense of the less common genera ( Figure 6C ).
5 9
The Community Model Predicts that Pathogen Dominance is Driven by Metabolite Cross-feeding 2 6 0
To investigate putative metabolic mechanisms by which pathogens may establish dominance in the CF 2 6 1 lung, we used model predictions to quantify rates of metabolite cross-feeding between species. For each 2 6 2 rare pathogen (Escherichia, Burkholderia and Achromobacter), 100 simulations performed with 2 6 3 randomized community uptake rates were used to calculate average exchange rates of the five most 2 6 4 significantly cross-fed metabolites between Pseudomonas, Streptococcus and the pathogen of interest. 2 6 5
The overall metabolite exchange rate from one species to another species was calculated by determining 2 6 6 the minimum uptake or secretion rate for each exchanged metabolite and then summing these minimum 2 6 7 rates over all exchanged metabolites.
3
Escherichia was predicted to consume the organic acids acetate, formate and L-lactate produced by 2 6 9
Streptococcus, while Streptococcus benefitted from the amino acids serine and threonine secreted by 2 7 0 Escherichia ( Figures 7A and 7D ). Due to the existence of alternative optima with respect to the secretion 2 7 1 products (49), L-lactate secretion was not predicted in Streptococcus monoculture even through the 2 7 2 metabolic reconstruction supported L-lactate production (19) [www.vmh.life]. While Streptococcus 2 7 3 strains are well known to product L-lactate as the primary product via homolactic fermentation (50, 51), 2 7 4
we chose not to manually curate the metabolic reconstruction since in silico L-lactate synthesis was 2 7 5 induced by the presence of other community members such as Escherichia. Pseudomonas was minimally 2 7 6 involved in metabolite exchange due to its low average abundance (~1%) across the 100 simulations.
7 7
Hence, our model suggested that organic acid cross-feeding could play a role in Enterobacteriaceae 2 7 8 propagation in the CF lung. 2 7 9
More complex cross-feeding relationships were predicted for Burkholderia-containing communities that 2 8 0 Compared to the other two pathogens, Achromobacter was predicted to be less efficient at cross-feeding 2 9 1 having only small uptake rates of alanine, L-lactate and threonine secreted by the other two species. By 2 9 2 contrast, Pseudomonas was predicted to benefit from relatively large uptake rates of formate produced by 1 4
Streptococcus and succinate produced by Achromobacter. Collectively, these model predictions could 2 9 4 help explain the enhanced ability of Burkholderia to dominate the simulated CF airway communities 2 9 5 compared to Achromobacter (Figure 4 ) despite the single-species growth rates of the two species being 2 9 6 similar ( Figure 3 ). 2 9 7
Similar cross-feeding analyses were performed for 1000 simulations with randomized nutrient uptake 2 9 8 rates in 14-species communities lacking Escherichia, Burkholderia and Achromobacter. To investigate 2 9 9 the possibility of differential cross-feeding patterns, the simulations were split into 500 cases with the 3 0 0
highest Pseudomonas abundances and 500 cases with the lowest Pseudomonas abundances ( Figure 8A ). 3 0 1
For each set of 500 simulations, the average exchange rates of the five most significantly cross-fed 3 0 2 metabolites between the four most abundant species (Pseudomonas, Streptococcus, Prevotella and 3 0 3
Staphylococcus) were calculated. The overall metabolite exchange rate between any two species were 3 0 4 calculated from the individual metabolite uptake and secretion rates as before. 3 0 5
When Pseudomonas abundances were predicted to be relatively high (average 61%), community 3 0 6 interactions were dominated by Pseudomonas consumption of formate, ethanol, acetate and aspartate 3 0 7 secreted by the other three species ( Figure 8B) . Formate cross-feeding was predicted to be particularly 3 0 8 important, which was consistent with an in vitro study showing that expression of the P. aeruginosa fdnH 3 0 9 gene ( encoding a formate dehydrogenase) was elevated in synthetic sputum medium compared to glucose 3 1 0 minimal media (52). Similarly, the expression of the P. aeruginosa adhA (encoding an alcohol 3 1 1 dehydrogenase) was elevated in patient-derived CF sputum compared to in vitro rich medium (53). Since 3 1 2 P. aeruginosa strains have the capability to uptake both formate and ethanol (54, 55), these in vitro 3 1 3 studies suggest that this cross-feeding mechanism could occur in CF airway communities. Staphylococcus 3 1 4 was the major source of exchanged formate and ethanol ( Figure 8D ), a prediction consistent with studies 3 1 5
showing that P. aeruginosa benefits from the presence of S. aureus (47, 56) . Both alanine and aspartate 3 1 6
have been shown to serve as preferred carbon sources for P. aeruginosa in a minimal medium 3 1 7 supplemented with lyophilized CF sputum (52). However, the ensemble model did not predict exchange 3 1 8 of L-lactate between P. aeruginosa and S. aureus, which differs from coculture experiments that mimic 3 1 9 the CF lung environment (47). Strong interactions between P. aeruginosa and various Streptococci also 3 2 0 have been reported (28), although the importance of metabolite cross-feeding in mediating these 3 2 1 interactions remains incompletely understood (57). Finally, in the model Pseudomonas supplied small 3 2 2 amounts of D-lactate for Prevotella and Staphylococcus consumption, a prediction consistent with an in 3 2 3 vitro study showing P. aeruginosa anaerobic production of the LldA enzyme catalyzing D-lactate 3 2 4 synthesis (58). 3 2 5
When Pseudomonas abundances were predicted to be relatively low (average 32%), metabolite cross-3 2 6 feeding remained dominated by Pseudomonas consumption of secreted byproducts and amino acids 3 2 7 ( Figure 8C ). Pseudomonas was predicted to have high consumption rates of formate produced by all three 3 2 8 other species and L-lactate synthesized only by Streptococcus, consistent with the ability of S. salivarius 3 2 9
(59) and P. aeruginosa (47) to synthesize and consume L-lactate, respectively. Higher exchange rates 3 3 0 between Streptococcus and Staphylococcus were predicted when Pseudomonas abundances were 3 3 1 relatively low ( Figure 8E ). The two species cross-fed alanine and L-lactate produced by Streptococcus, 3 3 2 and aspartate and ethanol secreted by Staphylococcus. Our predicted cross-feeding relationships in 3 3 3
Pseudomonas-and Streptococcus-dominated communities could provide insights into CF disease 3 3 4 progression, as high abundances of Streptococcus relative to Pseudomonas has been shown to correlate to 3 3 5 higher diversity airway communities and improved CF clinical stability (28). and how these interactions impede or promote disease progression. Metabolomics represents a powerful 3 4 4 tool to interrogate the complex metabolic environment of the CF lung (60), but the number and depth of 3 4 5 studies published to date has been limited. Metabolic modeling is a complementary tool for probing 3 4 6 complex microbial communities and their interactions mediated through competition for host-derived 3 4 7 nutrients and cross-feeding of secreted metabolites (11). Community metabolic models can provide 3 4 8 information difficult to obtain by purely experimental means, such as the combined impact of nutrient 3 4 9 environment and metabolic interactions on community composition. Metabolic models also can predict 3 5 0 the rates of metabolite exchange between species and identify cross-feeding relationships difficult to 3 5 1 delineate through metabolomic analyses. 3 5 2
We used 16S rRNA gene sequence data from three published studies (26-28) to construct and test a 3 5 3 metabolic model for prediction of airway community compositions in adult CF patients. The assembled 3 5 4 dataset consisted of 75 distinct samples from 46 patients who were judged to be stable or recovered from 3 5 5 treatment in the original studies. Principal component analysis performed on 16S read data showed 3 5 6 considerable heterogeneity of community composition across the 75 samples, including three patients 3 5 7 infected with Enterobacteriaceae, Burkholderia and Achromobacter pathogens. Interestingly, each of 3 5 8 these three patients was infected by only one of these "rare" pathogens, a characteristic we used to 3 5 9 1 7 Achromobacter xylosoxidans), and 11 other species commonly observed in the CF sputum samples (e.g. 3 6 9
Prevotella melaninogenica, Rothia mucilaginosa, Fusobacterium nucleatum). The 17 modeled taxa 3 7 0 provided substantial coverage of the read data with an average coverage of 95.6+/-3.9% across the 75 3 7 1 samples. Because our in silico objective of growth rate maximization tends to produce low diversity 3 7 2 communities dominated by ~5 species (39), the relatively low diversity of these adult CF lung samples 3 7 3 made them particularly well suited for analysis through metabolic modeling as compared to considerably 3 7 4 more diverse bacterial communities found elsewhere in the human body (e.g. intestinal tract (39, 61); 3 7 5 chronic wounds (62)).
7 6
The community metabolic model required specification of host-derived nutrients that mimicked the CF 3 7 7 lung environment in terms of the nutrients available, their allowed uptake rates across the community, and 3 7 8 their allowed uptake rates by individual species. Given that the 17-species model contained 271 3 7 9 community uptake rates and a total of 2,378 species-specific uptake rates, a model tuning method was 3 8 0 developed to manage the daunting complexity. A putative list of host-derived nutrients was compiled by 3 8 1 starting with the synthetic sputum medium SCFM2 (63) and adding other nutrients either required for 3 8 2 monoculture growth of at least one modeled species, measured in metabolomic analyses of CF sputum 3 8 3 samples or identified through in silico analyses. The resulting 81 nutrients were separated into 14 distinct 3 8 4 groups to facilitate tuning of nominal community uptake rates to qualitatively match average read data for 3 8 5 the rare pathogen samples and the Pseudomonas/Streptococcus-dominated samples. This tuning process 3 8 6 proved to be the bottleneck of model development even under the simplifying assumption that the species 3 8 7 uptake rates were not limiting. A more streamlined and experimentally-driven tuning process would be 3 8 8 facilitated by the availability of matched 16S and metabolomics data for large sets of CF sputum samples. 3 8 9
Despite the challenges associated with defining physiologically-relevant nutrient uptake rates, the 3 9 0 community model was able to predict species abundance in qualitative agreement with average read data 3 9 1
for Enterobacteriaceae-, Burkholderia-, Achromobacter-and Pseudomonas/Streptococcus-dominated 3 9 2 samples. The modeling effort was simplified by omitting the other two rare pathogens when simulating 3 9 3 the 3 Enterobacteriaceae-, 3 Burkholderia-and 2 Achromobacter-containing samples and omitting all 3 9 4 three rare pathogens when simulating the other 67 samples, as justified through analysis of the 16S rRNA 3 9 5 gene sequence data. The 15-species models used to simulate the rare pathogen-containing samples were 3 9 6 able to reproduce dominance of the associated pathogen and, to a lesser extent, the abundances of less 3 9 7 prevalent species. However, satisfactory prediction of the 2 Achromobacter-containing samples required 3 9 8
the addition of four carbon sources (arabinose, fumarate, galactonate, xylose) which have not been 3 9 9 measured in the CF lung to our knowledge. While there is some experimental evidence to support their 4 0 0 inclusion, the need to add these four metabolites to elevate in silico Achromobacter growth could point to 4 0 1 limitations of the modeled nutrients and their defined uptake rates. 4 0 2
The 14-species model used to simulate the rare pathogen-free samples predicted that Pseudomonas and 4 0 3
Streptococcus would be the dominant genera, and that Prevotella and Staphylococcus also would be 4 0 4 present in the community. These predictions provided qualitative agreement with the 16S rRNA gene 4 0 5 sequence read data averaged across the 67 samples, although the predicted abundance of Prevotella was 4 0 6 comparatively high and the predicted diversity was comparatively low. Given the uncertainty associated 4 0 7 with identifying host-derived nutrients and translating these available nutrients into appropriate 4 0 8 community uptake rates, we considered our predictions to provide satisfactory in silico recapitulation of 4 0 9 measured community compositions across the set of four dominant CF pathogens. 4 1 0 A hallmark of CF lung infections is poorly understood differences in bacterial community compositions 4 1 1 between patients and in longitudinal samples collected from a single patient (40). We performed 4 1 2 simulations to test the hypothesis that these differences might be partially attributable to sample-to-4 1 3 sample variations in the nutrient environment in the CF lung. Nutrient variability was simulated by 4 1 4 randomizing the community uptake rates around their nominal values found through manual model 4 1 5 tuning. We performed 100 model ensemble simulations for each 15-species community containing a rare 4 1 6 pathogen to determine if the associated patient samples could be well fit by a simulated sample. Using the 4 1 7 least-squares difference between the measured reads and predicted abundances as the goodness-of-fit 1 9 measure, we found that the model ensembles could satisfactorily reproduce the community compositions 4 1 9 of the 8 rare pathogen-containing samples. The best-fit models tended to provide good predictions of rare 4 2 0 pathogen reads due their relatively large values (average 65% across the 8 samples), while the accuracy of 4 2 1 read predictions for less prevalent species was more variable. 4 2 2
Due to the availability of a much larger dataset of 67 patient samples, the rare pathogen-free model 4 2 3 consisting of 14 species afforded an opportunity to investigate sample-to-sample heterogeneity in more 4 2 4 depth. We performed 1000 model ensemble simulations with randomized nutrient uptake rates to find 4 2 5 best-fit models. Patient samples with relatively high Pseudomonas reads tended to be well fit because the 4 2 6 model predicted Pseudomonas dominance over a wide range of nutrient conditions. Less accurate but still 4 2 7 satisfactory fits were obtained for patient samples with moderate Pseudomonas and relatively high 4 2 8
Streptococcus reads. The model ensemble proved somewhat deficient in fitting samples with high reads 4 2 9
of Prevotella or of the less common genera Haemophilus, Rothia and Fusobacterium. This deficiency 4 3 0 could be attributable to the in silico lung environment not containing key nutrients and/or not specifying 4 3 1 sufficiently large uptake rates of supplied nutrients to support high abundances of these genera. 4 3 2
The quality of sample fits also was correlated to the sample diversity, with the best fits having the lowest 4 3 3 average diversity (inverse Simpson index of 0.10), moderate fits having an intermediate average diversity 4 3 4 (inverse Simpson index of 0.18), and poor fits having the highest average diversity (inverse Simpson 4 3 5 index of 0.23). For these three sets of samples, the best-fit models had average diversities of 0.10, 0.16 4 3 6 and 0.20, respectively. We believe that the lower predicted diversities were attributable to the modeling 4 3 7 assumption that the CF lung community maximizes its collective growth rate. Using a community 4 3 8 metabolic model of the human gut microbiota (39), we have shown that increased bacterial diversity 4 3 9
(typically associated with health) can be achieved by simulating suboptimal growth rates under the 4 4 0 hypothesis that disease progression correlates to a collective movement towards maximal growth.
0
reproduce more diverse samples, and rather simulate conditions associated with disease, such as 4 4 3 dominance of a single pathogen. 4 4 4
By optimizing cross-feeding of secreted metabolites, the community model was able to predict the 4 4 5 coexistence of multiple species at the maximal community growth rate rather than just predicting a 4 4 6 monoculture of the single species with the highest monoculture growth rate. Because the SteadyCom 4 4 7 method (25) used to formulate and solve the community model does not allow direct incorporation of 4 4 8 mechanisms by which one species could inhibit the growth of another species other than by nutrient 4 4 9 competition, the predicted community growth rate always was greater than the highest individual growth 4 5 0 rate of the coexisting species. Consequently, the formulated model was incapable was capturing more 4 5 1 complex interactions such as Pseudomonas secretion of diffusible toxins that inhibit the growth of other 4 5 2 CF pathogens (64). 4 5 3
Despite this limitation, the community model could be analyzed to understand the putative role of 4 5 4 metabolite cross-feeding in shaping community composition. The model predicted that the rare pathogens 4 5 5
Escherichia and Burkholderia were particularly efficient cross-feeders, using acetate, formate and other 4 5 6 secreted metabolites to establish dominance over less harmful bacteria. By contrast, the model predicted 4 5 7
Achromobacter to be substantially less adept at exploiting secreted metabolites for growth enhancement. 4 5 8
While we were able to simulate Achromobacter dominance through addition of four carbon sources 4 5 9 possibly present in the CF lung, the model suggested that other non-modeled mechanisms may be 4 6 0 involved in promoting Achromobacter expansion. One possibility is that Achromobacter utilizes its 4 6 1 ability to form multispecies biofilms (44, 65) to establish favorable metabolic niches for enhanced 4 6 2 growth. 4 6 3
In the absence of the three rare pathogens, the model predicted that Pseudomonas would be the primary 4 6 4 beneficiary of cross-fed metabolites including acetate, alanine and L-lactate from Streptococcus and 4 6 5 aspartate, ethanol and formate from Staphylococcus. These complex cross-feeding relationships were an 4 6 6 emergent property of the community model that could not predicted from monoculture simulations and 4 6 7 2 1 are consistent with published experimental data presented above. For example, the single-species models 4 6 8 predicted that acetate, CO 2 and formate would be the primary secreted byproducts yet the community 4 6 9 model also cross-fed ethanol, D-lactate, L-lactate and succinate which were not predicted to be secreted in 4 7 0 any monoculture simulation. We hypothesized that model ensemble simulations with relatively high and 4 7 1 low Pseudomonas abundances would show differential cross-feeding patterns. While some of the specific 4 7 2 cross-fed metabolites changed between the two cases, cross-feeding from Streptococcus and 4 7 3 Our community metabolic model generated several predictions that could be tested experimentally with 4 7 9 an appropriately designed in vitro community. For example, a 5-species in vitro system consisting of 4 8 0
Pseudomonas aeruginosa, Streptococcus sanguinis, Prevotella melaninogenica, Haemophilus influenzae 4 8 1
and Staphylococcus aureus would provide substantial coverage of our 16S rRNA gene sequencing data as 4 8 2 the five genera account for 81% of reads across the 75 samples and greater than 75% of reads in 56 4 8 3 samples. Specific model predictions that could be tested in vitro include the variability of community 4 8 4 compositions by changing nutrient levels in a synthetic CF medium, and the cross-feeding of specific 4 8 5 metabolites by genetically altering the secretion and/or uptake capabilities of these metabolites in the 4 8 6 relevant species. The availability of such in vitro data linking the nutrient environment, cross-feeding 4 8 7 mechanisms and community composition would allow direct testing of a simplified 5-species model and combined and represented as a single genus. To allow direct comparison with the species abundances 5 0 0 predicted by the model, the reads for each sample were normalized over the 17 modeled genera to sum to 5 0 1 unity (Table S3 ). 5 0 2
Community Metabolic Model: For simplicity, each genus was represented by a single species commonly 5 0 3 observed in CF airway communities (1, 6-9, 66), although we note that genera such as Streptococcus (28) 5 0 4
can have considerably diversity with respect to species representation. As mentioned above, the combined 5 0 5
Enterobacteriaceae/Escherichia taxonomic group was represented by the single species Escherichia coli. 5 0 6
A genome-scale metabolic reconstruction for each species ( Figure 1C ) was obtained from a large database 5 0 7 of AGORA models (19) (www.vmh.life). Table 1 lists the representative strain used for each genus, the 5 0 8 normalized reads fractionally associated with each genus averaged across the 75 samples (also shown in 5 0 9 Figure 1B) , and the number of samples for which the normalized reads exceeded 1%. The community 5 1 0 model accounted for 13,845 genes, 19,034 metabolites and 22,412 reactions within the 17 species as well 5 1 1 as 271 uptake and secretion reactions for the extracellular space shared by the species. 5 1 2
The genera Pseudomonas, Streptococcus and Prevotella dominated most communities, both in terms of 5 1 3 average reads for individual samples and the number of samples in which they exceeded 1%. 5 1 4
Interestingly, Enterobacteriaceae/Escherichia, Burkholderia and Achromobacter exceeded 0.1% in only 5 1 5 single patients represented by 3, 3, and 2 samples, respectively. Moreover, no patients were infected by 5 1 6 more than one of these "rare" pathogens, as the maximum reads of the other two pathogens never 5 1 7 2 3 exceeded 0.1% in these 8 samples. Therefore, for modeling purposes the 75 samples were partitioned 5 1 8 into: 3 Enterobacteriaceae/Escherichia-containing samples with Burkholderia and Achromobacter 5 1 9 absent; 3 Burkholderia-containing samples with Enterobacteriaceae/Escherichia and Achromobacter 5 2 0 absent; 2 Achromobacter-containing samples with Enterobacteriaceae/Escherichia and Burkholderia 5 2 1 absent; and 67 samples with all three rare pathogens absent. 5 2 2
Model Tuning and Simulation: The nutrient environment in the CF lung is complex and expected to vary 5 2 3 between patients as well as between longitudinal samples for individual patients depending on disease 5 2 4 state. While metabolomic analyses have been performed on CF sputum and bronchoscopy samples (40, 5 2 5 60, 66, 67), these studies were insufficient to define supplied nutrients for the metabolic model due to 5 2 6 their limited metabolite coverage. Furthermore, we found that based on our model, the synthetic sputum 5 2 7 medium SCFM2 used in previous in vitro CF microbiota studies (63, 68) would not support growth of 5 2 8
any of the 17 modeled species due to the lack of ions (Co 2+ , Cu 2+ , Mn 2+ , Zn 2+ ), amino acids (asparagine, 5 2 9 glutamine) and other metabolites (see below) essential for growth. While the medium likely would 5 3 0 contain trace amounts of the missing ions, the requirement of these other metabolites for growth suggests 5 3 1 limitations for the AGORA metabolic models with respect to biosynthetic pathways leading to biomass 5 3 2 formation. Given the semi-curated nature of the AGORA models (19), such discrepancies were expected 5 3 3 and had to be addressed by adding the missing essential metabolites to the modeled medium. A final 5 3 4 complication was that the community model required specification of nutrient uptake rates, which were 5 3 5 unknown even if medium component concentrations were specified due to the lack of species-dependent 5 3 6 uptake kinetics for each nutrient. Because such uptake information is rarely available even for highly 5 3 7 studied model organisms such as Escherichia coli (69), a simplified approach was used to define nutrient 5 3 8 uptake rates for the community model. 5 3 9
Supplied nutrients in the community model were defined by starting with the SCFM2 medium and adding 5 4 0 the four ions and two amino acids listed above. We found that each species required additional 5 4 1 metabolites in the medium to support biomass formation. These 29 additional metabolites were identified and added to the modeled medium such that all 17 species were capable of monoculture growth (see 5 4 3 Table S4 ). For example, the P. aeruginosa model required addition of uracil and menaquinone 7, while in 5 4 4 vitro experiments have shown that these metabolites are synthesized de novo and not required in the 5 4 5 medium (63). Next, we added four carbon sources (fructose, maltose, maltotriose, pyruvate) and 8 other 5 4 6 metabolites (adenosine, cytidine, glycerol, guanosine, hexadecanoate, inosine, octadecenoate, uridine) 5 4 7 measured in the CF lung (67) and the terminal electron acceptor O 2 to simulate aerobic respiration. 5 4 8
Finally, we added four additional carbon sources (arabinose, fumarate, galactonate, xylose) that increased 5 4 9
in silico Achromobacter growth such that Achromobacter would be competitive with other species when 5 5 0 it was present in the community. While these carbon sources were identified in silico, there is 5 5 1 experimental evidence to support their inclusion in the simulated CF lung environment. Fumarate has 5 5 2 been shown to be elevated in sputum samples from young CF patients (70). Arabinose and xylose are 5 5 3 constituents of extracellular polymer substance (EPS) produced by common human pathogens including 5 5 4 the modeled genera Pseudomonas, Staphylococcus and Escherichia (71), suggesting their possible 5 5 5 presence in the CF lung. Pathogenic Achromobacter strains isolated from CF patients has been shown to 5 5 6 grow on galactonate as a sole carbon source (72), supporting the hypothesis that Achromobacter has 5 5 7 evolved to utilize galactonate available in the CF lung. 5 5 8
The community uptake rates of the 86 supplied nutrients were tuned by trial-and-error to produce species 5 5 9 2 5
Because these nutrient uptakes rates were derived for the entire patient population and not an individual 5 6 8 patient sample, a different strategy was used to simulate sample-to-sample heterogeneity based on the 5 6 9 hypothesis that differences in nutrient availability could account for heterogeneity in measured reads. 5 7 0
Individual patient samples were simulated by randomly perturbing the community uptake rate for each of 5 7 1 the 14 nutrient groups listed above between 33% and 300% of its nominal value. Uniformly distributed 5 7 2 random numbers were generated for each group such that the number of cases with the uptake rates in the 5 7 3 range [33%-100%) and [100%-300%] were statistically equal. The bounds used for the uptake rate of 5 7 4 each metabolite also are listed in Table S4 . 5 7 5
Community Simulations: We used the SteadyCom method (25) to perform community simulations as 5 7 6 detailed in our previous study on the human gut microbiota (39). SteadyCom performs community flux 5 7 7 balance analysis by computing the relative abundance of each species for maximal community growth 5 7 8 while ensuring that all metabolites are properly balanced within each species and across the community. 5 7 9
Each species model used a non-growth associated ATP maintenance (ATPM) value of 5 mmol/gDW/h, 5 8 0 which is within the range reported for curated bacterial reconstructions. Cross-feeding of all 21 amino 5 8 1 acids and 8 common metabolic byproducts (acetate, CO 2 , ethanol, formate, H 2 , D-lactate, L-lactate, 5 8 2 succinate) was promoted by increasing the maximum nutrient uptake rates of these nutrients in each 5 8 3 species model to 2.5 and 5 mmol/gDW/h, respectively. Outputs of each SteadyCom simulation included 5 8 4 the community growth rate, the abundance of each species, and species-dependent uptake and secretion 5 8 5 rates of each extracellular metabolite. The nominal nutrient uptake rates produced a single community not 5 8 6 directly comparable to any single patient sample ( Figure 1E ), while each set of randomized uptake rates 5 8 7 produced a unique community that was interpreted as a prediction of an individual patient sample ( Figure  5  8 Firmida MC, Marques EA, Leao RS, Pereira RHV, Rodrigues ERA, Albano RM, Folescu TW, Table S1 . 16S sequencing reads for the top 72 taxonomic groups assembled from three published CF 9 0 3 studies. 9 0 4 Table S2 . 16S sequencing reads for the top 17 taxonomic groups assembled from three published CF 9 0 5 studies. 9 0 6 Table S3 . Normalized 16S sequencing reads for the top 17 taxonomic groups assembled from three 9 0 7 published CF studies. 9 0 8 Table S4 . Minimum, nominal and maximum community uptake rates for supplied nutrients. 9 0 9 Table S7 . Comparison of normalized reads and model predicted abundances for 8 patients samples 9 1 3 containing the pathogen Enterobacteriaceae/Escherichia, Burkholderia and Achromobacter. 9 1 4 Table S8 . Comparison of normalized reads and model predicted abundances for 9 representative patient 9 1 5 samples not containing the pathogens Enterobacteriaceae/Escherichia, Burkholderia or Achromobacter. 9 1 6 9 1 7
